Gold nanoparticles have shown potential in reversing the mesenchymal phenotype in various cancer types by inhibiting EMT markers, such as vimentin and N‐cadherin, while enhancing E‐cadherin expression [147]. This evidence concerns the gene CDH2 and cancer.